期刊文献+

慢性肝病伴结核病时化疗方案的选择及肝损害的防治对策 被引量:17

The choice of chemotherapy on hepatic disease cases with tuberculosis and the method to protect hepatic from damage
下载PDF
导出
摘要 目的探讨慢性肝病伴结核病时化疗方案的选择及肝损害的防治对策。方法170例慢性肝病伴结核病的患者在化疗前常规的作肝功能检测,并根据临床类型及其程度选择不同的化疗方案。对乙肝病毒复制指标阳性伴肝炎活动的患者进行抗病毒治疗。结果肝损害的发生率或恶化率慢性HBV携带者<酒精性肝病、脂肪性肝病<慢性肝炎轻度<慢性肝炎中度<慢性肝炎重度、肝硬化(P<0.01);抗病毒治疗的乙型肝炎肝损害的加重或恶化率低于非抗病毒治疗组(P<0.05);综合疗法与单纯化疗者肝损害好转与恶化的发生率和结核病的转归之间有明显的差异(P<0.01)。结论对于慢性肝病伴结核病的患者,化疗前要做好肝功能状况的评估工作,并依据肝病的临床类型及其程度选择合适的化疗方案,对肝损明显及某些特殊群体要加强抗炎、护肝、免疫、增强等措施,伴HBV复制的活动性乙肝同时进行抗病毒治疗。 Objective To observe the choice of chemotherapy on hepatic disease cases with tuberculosis and to explore the method to protect hepatic from damage. Method The study was undertaken by evaluating and appraising 170 chronic hepatic disease cases with tuberculosis patients hepatic function before taking chemotherapy. According to the different types and degrees of the chronic hepatic disease, different types of chemotherapy were chosen. If the index of HBV reproducing was positive, the patients were treated by resisting virus. Results The degree of liver damage was identified in a ascending order as following: No symptom and carrier of HBV, alcoholic hepatic disease, low level chronic hepatic disease, middle level chronic hepatic disease, high level chronic hepatic disease, and hepatic hardening ( P 〈 0.01 ). The use of anti - virus had better treatment effects than not using it ( P 〈 0. 05 ). The improvement rates were different between those who had comprehensive treatment plan and those who had simple chemotherapy alone (P 〈 0. 01 ). Conclusion For the patients with chronic hepatic disease with tuberculosis, it is important to have liver function evaluated before taking chemotherapy. Choice of chemotherapy should be made based on clinical characteristics of liver diseases and the degree of damaged already done. For those with severe liver damage or special group of patients, measures and actions should be taken including anti -bacteria, liver protection, immunity, enhancement and strengthening. Anti - virus treatment can also be given for those with index of HBV reproducing being positive.
出处 《临床肺科杂志》 2008年第6期741-744,共4页 Journal of Clinical Pulmonary Medicine
关键词 慢性肝病伴结核病 化疗方案 肝损害 临床分析 chronic hepatic disease with tuberculosis, chemotherapy, damage to hepatic, protection of hepatic from damage.
  • 相关文献

参考文献8

二级参考文献32

  • 1张凤池.大剂量胸腺肽对老年肺结核的近期疗效观察[J].临床肺科杂志,2004,9(6):687-687. 被引量:6
  • 2张培元,陈东宁,张红.肺结核合并肝硬化24例临床分析[J].中国防痨杂志,1995,17(4):165-166. 被引量:8
  • 3邢同京,陈加保,张光曙,甘天福,丁明权,阎承玉.利福平与异烟肼合用致肝损害的临床与病理分析[J].中华结核和呼吸杂志,1997,20(1):33-35. 被引量:80
  • 4Enarson DA, Chretien J. Epidemiology of respiratory infection diseases. Curr Opin Pulm Med, 1999 ;5 : 128.
  • 5Helsal E, Arnadottir T, Cruz JR, et al. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of chronic patients. Int J Tuberc Lung Dis,2001 ;5(2) :129.
  • 6Jana N, Vasishta K, Saha SC, et al. Obstetrical outcomes among women with extra- pulmonary tuberculosis. N Engl J Med, 1999;341:645.
  • 7Sequeira W, Colt, Block JA. Osteo-articular tuberculosis: current diagnosis and treatment. Am J Ther,2000;7(6) :393.
  • 8Migliori GB, Raviglione MC, Schabearg MC, et al. Tuberculosis management in Europe. Eur Respir J, 1998 ; 14:978.
  • 9Anthony D. Tuberculosis in Mrica: Clinical presentation and management. Pharmacol Ther 1997,73 ( 1 ) : 1.
  • 10Walley JD, Khan MA. Low rate of emergence of drug resistance in sputum positive patients treated with short-course chemotherapy. Int J Tuberc Lung Dis,2001 ;5( 1 ) :40.

共引文献18236

同被引文献83

引证文献17

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部